Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma

An obstacle to effective uniform treatment of glioblastoma, especially at recurrence, is genetic and cellular intertumoral heterogeneity. Hence, personalized strategies are necessary, as are means to stratify potential targeted therapies in a clinically relevant timeframe. Functional profiling of dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratliff, Miriam, Kim, Hichul, Qi, Hao, Kim, Minsung, Ku, Bosung, Azorin, Daniel Dominguez, Hausmann, David, Khajuria, Rajiv K., Patel, Areeba, Maier, Elena, Cousin, Loic, Ogier, Arnaud, Sahm, Felix, Etminan, Nima, Bunse, Lukas, Winkler, Frank, El-Khoury, Victoria, Platten, Michael, Kwon, Yong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223608/
https://www.ncbi.nlm.nih.gov/pubmed/35743016
http://dx.doi.org/10.3390/ijms23126572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223608/
https://www.ncbi.nlm.nih.gov/pubmed/35743016
http://dx.doi.org/10.3390/ijms23126572

Ejemplares similares